Meningococcal Disease, Invasive

Meningococcal Disease, Invasive

Reporting Guidelines:

  • Within 24 hours to local health department


  • West Virginia IDEP Protocol

Current Case Definition:

  • CDC Case Definition

Required Forms:

  • WVEDSS Invasive Bacterial Disease – Neisseria meningitidis Case Report

General Information:

  • Provider Information
  • Public Information
  • WV Office of Laboratory Services Transport Guidelines for Fastidious Organisms
  • MCV4 Vaccine failure and AST Letter

Surveillance Data:

  • West Virginia Meningococcal Disease, Invasive surveillance data from 1997-2006
  • Meningococcal Disease, Invasive, by Age Group 1995-2005
  • Meningococcal Disease, Invasive, by Month of Onset 1995-2005
  • Meningococcal Disease, Invasive, by Year of Onset 1995-2005
  • Meningococcal Disease, Invasive, by Serogroup and Year of Onset 2000-05

Other Links:

  • National Foundation for Infectious Disease
  • Guillain-Barre Syndrome Among Adolescents Who Received Meningococcal Conjugate Vaccine, Fact Sheet for Healthcare Professionals
  • Guillain-Barre Syndrome Among Recipients of Menactra Meningococcal Congugate Vaccine – United States, June–July 2005
  • FDA and CDC Issue Alert on Menactra Meningococcal Vaccine and Guillain Barré Syndrome
  • CDC Information: Meningococcal Disease, Invasive
  • Prevention and Control of Meningococcal Disease – Recommendations of the ACIP
  • Prevention and Control of Meningococcal Disease and Meningococcal Disease and College Students – Recommendations of the ACIP
  • Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the ACIP
  • Laboratory-Based Surveillance for Meningococcal Disease in Selected Areas, United States, 1989-1991:
  • Meningococcal Disease and College Students: Recommendations of the Advisory Committee on Immunization Practices
  • CDC Guidelines for Vaccinating Pregnant Women
  • Emergence of Fluoroquinolone-Resistant Neisseria meningitidis- Minnesota and North Dakota 2007-2008
  • Recommendation from the ACIP for USe of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 years at Increased Risk for Invasive Menningococcal Disease


Leave a Reply

Your email address will not be published. Required fields are marked *